FDA clearance enables market access for a new device from DAXOR.
2 reports, 1 independent
Updated Jul 1
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA clearance enables market access for a new device from DAXOR.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Policymakers are considering ways to influence the drug market, including potential changes to patent rights and the FDA approval process.
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.
- FDA approval expands patient access to therapies for ACCORD.
- Profusa, Inc. achieved ISO certification, enabling EU market entry, with the standard aligning with FDA QMSR.
Coverage
Newest first; wire copies grouped- GlobeNewswireDaxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System Management Expects High Demand Driven by Speed, Simplicity, and Clinical Precision Oak Ridge, TN, Aug